Physiological roles of PKB/Akt isoforms in development and disease

Dummler, B., Hemmings, B.A.·2007·Biochemical Society Transactions

DOI 10.1042/bst0350231

Cited by (323)

Items 301–323 of 323

Additional file 1 of Translating traditional herbal formulas into modern drugs: a network-based analysis of Xiaoyao decoction
Daiyan Zhang, Yun Zhang, Yan Gao, Xingyun Chai, Rongbiao Pi, Ging Chan, Hu Yuanjia · 2020 · Figshare
Tumor Heterogeneity in Triple-Negative Breast Cancer: Shedding Light on the Role of AKT and RUNX
Antonella Vila, Natalia B. Fernández, Florencia Cascardo, Gonzalo M. Sánchez, Virginia Novaro, Natalia Rubinstein, Matı́as Blaustein · 2024 · Interdisciplinary cancer research
A new preparation process to afuresertib, a pan-AKT inhibitor under clinical development
Meidi Luo, Xintian Yu, Bo Jin, Jing Zhang, Boyang Wu, Dan Liu, Shaoning Wang, Yang Liu, Qun Feng Niu, Jiachen Wen · 2025 · Chemical Papers
Additional file 8 of In-depth phosphoproteomic profiling of the insulin signaling response in heart tissue and cardiomyocytes unveils canonical and specialized regulation
Jonathan Samuel Achter, Vega, Estefania Torres, Andrea Sorrentino, Konstantin Kahnert, Katrine Douglas Galsgaard, Pablo Hernández-Varas, Michael Wierer, Holst, Jens Juul, Wojtaszewski, Jørgen Frank Pind, Robert W. Mills et al. · 2024 · Figshare
Additional file 3 of In-depth phosphoproteomic profiling of the insulin signaling response in heart tissue and cardiomyocytes unveils canonical and specialized regulation
Jonathan Samuel Achter, Vega, Estefania Torres, Andrea Sorrentino, Konstantin Kahnert, Katrine Douglas Galsgaard, Pablo Hernández-Varas, Michael Wierer, Holst, Jens Juul, Wojtaszewski, Jørgen Frank Pind, Robert W. Mills et al. · 2024 · Figshare
Additional file 4 of In-depth phosphoproteomic profiling of the insulin signaling response in heart tissue and cardiomyocytes unveils canonical and specialized regulation
Jonathan Samuel Achter, Vega, Estefania Torres, Andrea Sorrentino, Konstantin Kahnert, Katrine Douglas Galsgaard, Pablo Hernández-Varas, Michael Wierer, Holst, Jens Juul, Wojtaszewski, Jørgen Frank Pind, Robert W. Mills et al. · 2024 · Figshare
Additional file 10 of In-depth phosphoproteomic profiling of the insulin signaling response in heart tissue and cardiomyocytes unveils canonical and specialized regulation
Jonathan Samuel Achter, Vega, Estefania Torres, Andrea Sorrentino, Konstantin Kahnert, Katrine Douglas Galsgaard, Pablo Hernández-Varas, Michael Wierer, Holst, Jens Juul, Wojtaszewski, Jørgen Frank Pind, Robert W. Mills et al. · 2024 · Figshare
Additional file 9 of In-depth phosphoproteomic profiling of the insulin signaling response in heart tissue and cardiomyocytes unveils canonical and specialized regulation
Jonathan Samuel Achter, Vega, Estefania Torres, Andrea Sorrentino, Konstantin Kahnert, Katrine Douglas Galsgaard, Pablo Hernández-Varas, Michael Wierer, Holst, Jens Juul, Wojtaszewski, Jørgen Frank Pind, Robert W. Mills et al. · 2024 · Figshare
Additional file 7 of In-depth phosphoproteomic profiling of the insulin signaling response in heart tissue and cardiomyocytes unveils canonical and specialized regulation
Jonathan Samuel Achter, Vega, Estefania Torres, Andrea Sorrentino, Konstantin Kahnert, Katrine Douglas Galsgaard, Pablo Hernández-Varas, Michael Wierer, Holst, Jens Juul, Wojtaszewski, Jørgen Frank Pind, Robert W. Mills et al. · 2024 · Figshare
Additional file 6 of In-depth phosphoproteomic profiling of the insulin signaling response in heart tissue and cardiomyocytes unveils canonical and specialized regulation
Jonathan Samuel Achter, Vega, Estefania Torres, Andrea Sorrentino, Konstantin Kahnert, Katrine Douglas Galsgaard, Pablo Hernández-Varas, Michael Wierer, Holst, Jens Juul, Wojtaszewski, Jørgen Frank Pind, Robert W. Mills et al. · 2024 · Figshare
Additional file 5 of In-depth phosphoproteomic profiling of the insulin signaling response in heart tissue and cardiomyocytes unveils canonical and specialized regulation
Jonathan Samuel Achter, Vega, Estefania Torres, Andrea Sorrentino, Konstantin Kahnert, Katrine Douglas Galsgaard, Pablo Hernández-Varas, Michael Wierer, Holst, Jens Juul, Wojtaszewski, Jørgen Frank Pind, Robert W. Mills et al. · 2024 · Figshare
Additional file 2 of In-depth phosphoproteomic profiling of the insulin signaling response in heart tissue and cardiomyocytes unveils canonical and specialized regulation
Jonathan Samuel Achter, Vega, Estefania Torres, Andrea Sorrentino, Konstantin Kahnert, Katrine Douglas Galsgaard, Pablo Hernández-Varas, Michael Wierer, Holst, Jens Juul, Wojtaszewski, Jørgen Frank Pind, Robert W. Mills et al. · 2024 · Figshare
Additional file 1 of In-depth phosphoproteomic profiling of the insulin signaling response in heart tissue and cardiomyocytes unveils canonical and specialized regulation
Jonathan Samuel Achter, Vega, Estefania Torres, Andrea Sorrentino, Konstantin Kahnert, Katrine Douglas Galsgaard, Pablo Hernández-Varas, Michael Wierer, Holst, Jens Juul, Wojtaszewski, Jørgen Frank Pind, Robert W. Mills et al. · 2024 · Figshare
Effets anti-tumoraux du VIP dans des cellules de neuroblastome
Madryssa de Boisvilliers · 2015 · theses.fr (ABES)
Le métabolisme des céramides hypothalamiques induit une résistance à l’insuline centrale et une dérégulation de l’homéostasie glucidique durant l’installation de l’obésité
Maria B. Campaña · 2017 · theses.fr (ABES)
Antimicrobial peptide LL-37 promotes proliferation of human bone marrow-derived mesenchymal stem cells
Putida Pinthonglor, Pareena Chotjumlong, Dumnoensun Pruksakorn, Jeerawan Klangjorhor, Patcharawadee Thongkumkoon, Worakanya Buranaphatthana, Sarawut Kumphune, Chayarop Supanchart · 2026 · Scientific Reports
Loss of Akt3 enhances antiviral immunity while disrupting corneal homeostasis during ocular HSV-1 infection
Rashmi Kadam, Chandrashekhar Devidas Patil, Hemant P. Borase, Rakesh Rahangdale, Ipsita Volety, Soromidayo Akinsiku, Deepak Shukla · 2026 · Frontiers in Immunology
Isoformselektive Adressierung der Proteinkinase Akt durch Kovalent‐allosterische Inhibition
Giovanni Danilo D’Angelo, Kosmas Alexandros Pervanidis, Ioannis Athanasiadis, Vladimir Lukianchikov, Andrea Scrima, Laura Depta, Sara Stier, Matthias Philipp Müller, Henner F. Farin, Lena Quambusch et al. · 2026 · Angewandte Chemie
Structure-Guided Scaffold Editing of Matrine Yields an AKT1-Selective Inhibitor with In Vivo Efficacy against Hepatocellular Carcinoma
Yongquan Wei, Die Sun, Zexu Xing, Lisheng Wang · 2026 · European Journal of Medicinal Chemistry
Nutraceuticals modulating Wnt/β-catenin and PI3K/mTOR kinase cascades in cancer therapeutics
Bhavna Bohra, Heena Chauhan, Mithun Singh Rajput, Anshu Srivastava, Ajay Kumar, Bhagawati Saxena · 2026 · Elsevier eBooks
BindingDB Entry 50031408: 2-Aminothiadiazole inhibitors of AKT1 as potential cancer therapeutics.
BindingDB · 2010 · UC San Diego
BindingDB Entry 2816: Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinase.
BindingDB · 2008 · UC San Diego
BindingDB Entry 50033863: Design and synthesis of novel amide AKT1 inhibitors with selectivity over CDK2.
BindingDB · 2012 · UC San Diego